Positron Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a POSC research report →
Price Chart
About the company
Positron Corporation is a healthcare firm specializing in nuclear medicine, with a core emphasis on cardiac Positron Emission Tomography (PET) imaging services throughout the United States. The company empowers healthcare providers by offering its proprietary Attrius PET scanner, comprehensive clinical and technical support, and flexible financing solutions. These integrated offerings enable medical professionals to precisely diagnose heart conditions, enhance patient health outcomes, and deliver medical care with greater cost-efficiency.
- CEO
- Adel Abdullah
- IPO
- 1999
- Employees
- 10
- HQ
- North Tonawanda, NY, US
Get TickerSpark's AI analysis on POSC
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $57.38M
- P/E
- -5.63
- PEG
- 0.05
- P/S
- 129.01
- P/B
- -86.85
- EV/EBITDA
- -5.86
- Div Yield
- 0.00%
- Gross Margin
- -531.90%
- Op Margin
- -2264.74%
- Net Margin
- -2280.56%
- ROE
- -1759.59%
- ROIC
- -1063.98%
Latest fiscal year · YoY change
- Revenue
- $461.45K-21.5%
- Gross Profit
- $-2,114,290-518.2%
- Op Income
- $-10,498,463
- Net Income
- $-10,603,392-344.0%
- EPS
- $-0.34-270.0%
- OCF Growth
- -171.6%
- FCF Growth
- -177.3%
- 52W High
- $2.74
- 52W Low
- $1.27
- 50D MA
- $1.75
- 200D MA
- $1.82
- Beta
- 0.14
- RSI (14)
- 47
- Avg Volume
- 18.79K
No earnings-call transcripts are available for POSC yet.
- Free Float
- 77.1%
- Shares Outstanding
- 32.85M
- Float Shares
- 25.31M
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 30, 14 | Conn Corey N | buy | 69,444,444 |
| Jun 30, 14 | Rooney Patrick G | buy | 277,777,777 |
| May 19, 14 | Conn Corey N | buy | 120,000,000 |
| May 19, 14 | Rooney Patrick G | buy | 407,200,000 |
| Nov 7, 13 | Rooney Patrick G | buy | 5,000,000 |
| Nov 7, 13 | Rooney Patrick G | buy | 2,500,000 |
| Apr 15, 13 | Conn Corey N | buy | 2,500,000 |
| Apr 15, 13 | Rooney Patrick G | buy | 5,000,000 |
| Jan 8, 10 | NICHOLLS ANTHONY C | sell | 15,000 |
| Dec 29, 10 | NICHOLLS ANTHONY C | other | 25,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our POSC coverage
Recent articles, reports, and earnings notes.
No research on POSC yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate POSC report →Positron Corp. (OTCMKTS:POSC) Sees Significant Increase in Short Interest
defenseworld.net · Oct 1
Positron Secures Multiple PET-CT Orders Amid Accelerating Shift to Cardiac PET
globenewswire.com · Jul 20
Head-To-Head Review: Positron (OTCMKTS:POSC) versus Pressure BioSciences (OTCMKTS:PBIO)
defenseworld.net · Apr 2
Contrasting Positron (OTCMKTS:POSC) and AngioDynamics (NASDAQ:ANGO)
defenseworld.net · Mar 11
Positron Corporation Secures Multiple PET-CT Orders from Leading Nuclear Cardiologist Practices
globenewswire.com · Feb 17
Reviewing Positron (OTCMKTS:POSC) and Tenon Medical (NASDAQ:TNON)
defenseworld.net · Feb 7
OPKO Health (NASDAQ:OPK) & Positron (OTCMKTS:POSC) Head-To-Head Review
defenseworld.net · Jan 16
Positron Corporation Announces Its Transition to a Reporting SEC Company
globenewswire.com · Nov 17
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.